A vaginal mesh is a medical device used to repair and reinforce the formation of broken tissue. Mesh material, which is synthetic, does not get completely absorbed by the body; thus, it is called permanent. Bovine and porcine sources can be used to make absorbable biologic mesh materials like acellular collagen which the body can break down in due time. Furthermore, composite materials may also make a vaginal mesh and is from a combination of biologic and synthetic materials.
A vaginal mesh is a medical device used for urogynecologic procedures which include repair of pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
The urethra is supported by means of mesh implants to the weakened walls of the vagina to treat women with POP. For SUI, the bladder neck is supported via a “sling” to prevent it from falling out of place.
Adverse effects from such medical devices because of the synthetic material used was shown during recent analysis. Treatment of displacement of vaginal organs in women should have been treated by these devices but instead made a lot of negative feedback. Thus, the U.S. Food and Drug Administration (FDA) have issued a new warning regarding the commonly used synthetic vaginal mesh. Three years prior to the FDA’s latest warning, more than 1,000 reports of complications associated with the vaginal mesh plus the addition of the not less than 2,800 women affected since the first warning was issued in 2008.
The new warning affirms that there is growing concern to the lingering high rate of adverse reports even though it is common for such adverse events to be reported following an FDA safety update. Bleeding, infection, urinary infections, bladder or bowel perforation, painful urination, Fistulas, narrowing of the vaginal wall, mesh shrinkage, mesh migration, painful sexual intercourse for both partners, recurrence of incontinence, recurrence of either POP or SUI, or both, tightening of the vagina and the most common complication, erosion are usually what’s reported.
Even though reviews for improving the vaginal mesh are under way, University of Utah Health Care officials are concerned of the inadequate education given to patients on the matter which are making the situation even more abominable. Awareness of complications and specialized training in mesh placement techniques are what the FDA wants for professionals to acquire. Different means of treating POP without cutting the body open are available and that is what the FDA urges sufferers to try.